Literature DB >> 31145414

Emergence of Hybrid Models of Genetic Testing Beyond Direct-to-Consumer or Traditional Labs.

Kathryn A Phillips1,2, Julia R Trosman1,3, Michael P Douglas1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31145414      PMCID： PMC6684382          DOI： 10.1001/jama.2019.5670

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer.

Authors:  Jonathan R Foote; Micael Lopez-Acevedo; Adam H Buchanan; Angeles Alvarez Secord; Paula S Lee; Cynthia Fountain; Evan R Myers; David E Cohn; Shelby D Reed; Laura J Havrilesky
Journal:  J Oncol Pract       Date:  2017-01-03       Impact factor: 3.840

2.  Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.

Authors:  Jennifer Gill; Adam J Obley; Vinay Prasad
Journal:  JAMA       Date:  2018-06-19       Impact factor: 56.272

3.  Gatekeepers or intermediaries? The role of clinicians in commercial genomic testing.

Authors:  Michelle L McGowan; Jennifer R Fishman; Richard A Settersten; Marcie A Lambrix; Eric T Juengst
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240
  3 in total
  5 in total

Review 1.  Evaluating Web-Based Direct-to-Consumer Genetic Tests for Cancer Susceptibility.

Authors:  Madison K Kilbride; Angela R Bradbury
Journal:  JCO Precis Oncol       Date:  2020-03-05

2.  Influence of payer coverage and out-of-pocket costs on ordering of NGS panel tests for hereditary cancer in diverse settings.

Authors:  Grace A Lin; Julia R Trosman; Michael P Douglas; Christine B Weldon; Maren T Scheuner; Allison Kurian; Kathryn A Phillips
Journal:  J Genet Couns       Date:  2021-07-07       Impact factor: 2.537

Review 3.  Cancer Genetic Counseling-Current Practice and Future Challenges.

Authors:  Jaclyn Schienda; Jill Stopfer
Journal:  Cold Spring Harb Perspect Med       Date:  2020-06-01       Impact factor: 5.159

4.  Attitudes and interest in incorporating BRCA1/2 cancer susceptibility testing into reproductive carrier screening for Ashkenazi Jewish men and women.

Authors:  Melanie W Hardy; Beth N Peshkin; Esther Rose; Mary Kathleen Ladd; Savannah Binion; Mara Tynan; Colleen M McBride; Karen A Grinzaid; Marc D Schwartz
Journal:  J Community Genet       Date:  2022-04-29

5.  Laboratory business models and practices: implications for availability and access to germline genetic testing.

Authors:  Maren T Scheuner; Michael P Douglas; Paloma Sales; Sara L Ackerman; Kathryn A Phillips
Journal:  Genet Med       Date:  2021-05-06       Impact factor: 8.822
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.